Bare metal stents versus drug eluting stents: where do we stand in 2015?

PM Meraj, R Jauhar, A Singh - Current treatment options in cardiovascular …, 2015 - Springer
Opinion statement The development of bare metal stent (BMS) was a major advancement
over plain old balloon angioplasty (POBA) in the management of symptomatic coronary …

Percutaneous coronary intervention: recommendations for good practice and training

KD Dawkins, T Gershlick, M De Belder, A Chauhan… - Heart, 2005 - heart.bmj.com
Cardiologists undertaking percutaneous coronary intervention (PCI) are excited by the
combination of patient and physician satisfaction and technological advance occurring on …

Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease

CA Yock, DB Boothroyd, DK Owens, AM Garber… - The American journal of …, 2003 - Elsevier
PURPOSE: To compare the cost-effectiveness of surgical and angioplasty-based coronary
artery revascularization techniques, in particular, angioplasty with primary stenting …

Coronary artery bypass is superior to drug-eluting stents in multivessel coronary artery disease

RA Guyton - The Annals of thoracic surgery, 2006 - Elsevier
Percutaneous intervention for the treatment of multivessel coronary artery disease continues
to displace coronary artery bypass graft surgery. But controlled trials of percutaneous …

Tissue engineered bovine saphenous vein extracellular matrix scaffolds produced via antigen removal achieve high in vivo patency rates

ML Higuita, JFL Giraldo, TL Sarrafian, LG Griffiths - Acta biomaterialia, 2021 - Elsevier
Diseases of small diameter blood vessels encompass the largest portion of cardiovascular
diseases, with over 4.2 million people undergoing autologous vascular grafting every year …

Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the …

BP Yan, DJ Clark, B Buxton, AE Ajani, JA Smith… - Heart, Lung and …, 2009 - Elsevier
OBJECTIVES: Controversy continues over the optimal revascularisation strategy for patients
with multi-vessel coronary artery disease. Clinical characteristics, risk profile, and mortality of …

HRQoL after coronary artery bypass grafting and percutaneous coronary intervention for stable angina

P Loponen, M Luther, K Korpilahti… - Scandinavian …, 2009 - Taylor & Francis
Objectives. To assess the health related quality of life (HRQoL) and the change in the NYHA
class after coronary artery bypass grafting (CABG) or percutaneous coronary intervention …

Coronary artery bypass grafting on the beating heart: surgical revascularization for the next decade?

GJ Murphy, R Ascione, GD Angelini - European heart journal, 2004 - academic.oup.com
This review considers whether coronary artery bypass grafting (CABG) performed on the
beating heart (off-pump or OPCAB) will supersede conventional CABG utilizing …

Comparison of drug-eluting stents and coronary artery bypass grafting for the treatment of multivessel coronary artery disease in patients with chronic kidney disease

ZJ Wang, YJ Zhou, YY Liu, DM Shi, YX Zhao… - Circulation …, 2009 - jstage.jst.go.jp
Background: Chronic kidney disease (CKD) is a strong predictor of mortality after
percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), but the …

Current status of off-pump coronary artery bypass surgery

SG Raja, GD Dreyfus - Asian Cardiovascular and Thoracic …, 2008 - journals.sagepub.com
The expanding indications for angioplasty coupled with the successful short and mid-term
results of randomized controlled trials of drug-eluting stents have already had an …